Cleared Traditional

K082607 - MRI-PLAQUE VIEW, VERSION 1.1.2003

K082607 is an FDA 510(k) clearance for MRI-PLAQUE VIEW, manufactured by Vpdiagnostics, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K082607 · Vpdiagnostics, Inc. · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Dec 2008
Decision
88d
Days
Class 2
Risk

K082607 is an FDA 510(k) clearance for the MRI-PLAQUE VIEW, VERSION 1.1.2003. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Vpdiagnostics, Inc. (Seattle, US). The FDA issued a Cleared decision on December 5, 2008 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K082607

510(k) Number K082607 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 08, 2008
Decision Date December 05, 2008
Days to Decision 88 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d faster than avg
Panel avg: 107d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2270
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K082607.
CT BRAIN PERFUSION FOR ZIOSTATION
K083084 · Ziosoft, Inc. · Dec 2008
PICTURE ARCHIVING AND COMMUNICATION SYSTEM (PACS), PETAVISION
K083555 · Emsoma Co., Ltd. · Dec 2008
VISAGE PACS, VERSION 6.0/CS 3.1
K082269 · Visage Imaging, Inc. · Dec 2008
NORDICICE SOFTWARE
K082441 · Nordicimaginglab AS · Nov 2008
SNTRYPACS
K082240 · Qstar Technologies, Inc. · Nov 2008
CMR42 CARDIAC MRI IMAGING SYSTEM, 2.1.23
K082628 · Circle Cardiovascular Imaging, Inc. · Nov 2008
K082607 · MRI-PLAQUE VIEW, VERSION 1.1.2003
Download PDF FDA Summary Vpdiagnostics, Inc.